Determination of L-365,260, a new cholecystokinin receptor (CCK-B) antagonist, in plasma by liquid chromatography/atmospheric pressure chemical ionization mass spectrometry
- 1 February 1992
- journal article
- research article
- Published by Wiley in Journal of Mass Spectrometry
- Vol. 21 (2), 63-68
- https://doi.org/10.1002/bms.1200210202
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Cholecystokinin and anxietyTrends in Pharmacological Sciences, 1990
- Cholecystokinin-4 and PanicArchives of General Psychiatry, 1990
- Cholecystokinin-Tetrapeptide Induces Panic Attacks in Patients with Panic DisorderThe Canadian Journal of Psychiatry, 1990
- The selective CCK-B receptor antagonist L-365,260 enhances morphine analgesia and prevents morphine tolerance in the ratEuropean Journal of Pharmacology, 1990
- Postponement of Satiety by Blockade of Brain Cholecystokinin (CCK-B) ReceptorsScience, 1989
- Cholecystokinin Tetrapeptide Induces Panic-like Attacks in Healthy VolunteersArchives of General Psychiatry, 1989
- A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor (CCK-B) ligand: L-365,260European Journal of Pharmacology, 1989
- Benzodiazepine gastrin and brain cholecystokinin receptor ligands; L-365,260Journal of Medicinal Chemistry, 1989
- Brain CCK receptors are structurally distinct from pancreas CCK receptorsBiochemical and Biophysical Research Communications, 1984
- CHOLECYSTOKININ: A HORMONE AND A NEUROTRANSMITTER Biomedical Research, 1982